Antipsychotics Have Been Linked to Diabetes Risk in Youth
Young people taking antipsychotic medications may face a higher long-term risk of developing Type 2 diabetes.
Updated on Sept. 19, 2026 in Diabetes
Live Poll
Should doctors prioritize behavioral therapy over medication for children with mild behavioral symptoms?
A large-scale study of 90,000 youths in the Netherlands found that long-term use of antipsychotic medications is associated with an increased incidence of Type 2 diabetes. The findings highlight the importance of monitoring metabolic health in young patients prescribed these treatments.
Why it matters
Understanding this connection is crucial for managing the long-term health of young patients on antipsychotic therapy, as early intervention may mitigate metabolic complications. Clinicians and families should weigh these risks when assessing the benefits of psychiatric treatment for children and teenagers.
In a study of 90,000 youths, researchers found that the rate of new diabetes cases increased from 2.5 per 10,000 users in the first year of antipsychotic use to over nine per 10,000 after five years. These results demonstrate a clear long-term association, though the specific biological triggers for each individual remain under investigation.
The details
Antipsychotics such as olanzapine can trigger metabolic changes by blocking M3 receptors on pancreatic cells, which restricts the body's ability to release insulin. Additionally, these medications disrupt liver signaling, causing the liver to release stored sugar into the bloodstream while interfering with the way muscle tissue absorbs blood sugar. These processes contribute to rapid weight gain, increased body fat, and significantly reduced insulin sensitivity.
Timeline
During the first year of use, 2.5 per 10,000 users developed diabetes.
After five years of use, more than nine per 10,000 users developed diabetes.
Health Landscape
This research adds to the ongoing monitoring of metabolic side effects in pediatric psychopharmacology, providing evidence of long-term diabetes risk. It underscores the broader shift toward integrating metabolic screening into routine mental health care for youth.
Parents and guardians of youths prescribed antipsychotics should prioritize regular metabolic health checkups with a physician to track weight and blood sugar. If you have concerns about a current prescription, consult with a doctor to discuss balancing mental health needs with metabolic safety.
The takeaway
This study demonstrates that antipsychotic medication use in youth can lead to a measurable increase in Type 2 diabetes risk over five years. Families should discuss routine glucose and weight monitoring with a prescribing physician to proactively manage these metabolic risks.
Further reading
For more information on managing metabolic health, visit the Diabetes section.
Source note: This article includes information reported by Theepochtimes.
Live Poll
Should doctors prioritize behavioral therapy over medication for children with mild behavioral symptoms?
